v3.26.1
Condensed Consolidated Statements of Changes in Equity (unaudited) - USD ($)
$ in Millions
Total
Total Baxter stockholders' equity
Common stock
Common stock in treasury
Additional contributed capital
Retained earnings
Accumulated other comprehensive income (loss)
Noncontrolling interests
Balance, beginning of period (in shares) at Dec. 31, 2024     683,000,000          
Balance, beginning of period (in usd) at Dec. 31, 2024 $ 7,024 $ 6,964 $ 683 $ (11,059) $ 6,421 $ 14,929 $ (4,010) $ 60
Balance, treasury, beginning period (in shares) at Dec. 31, 2024       173,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 217 217       217    
Other comprehensive income (loss) 149 149         149  
Reclassification of other comprehensive income (loss) disposed in the Kidney Care separation 115 115         115  
Stock issued under employee benefit plans and other (in shares)       (3,000,000)        
Stock issued under employee benefit plans and other 51 51   $ 144 (93)      
Dividends declared on common stock (176) (176)       (176)    
Disposition of noncontrolling interest associated with the Kidney Care separation (87)             (87)
Balance, end of period (in shares) at Jun. 30, 2025     683,000,000          
Balance, end of period (in usd) at Jun. 30, 2025 7,293 7,320 $ 683 $ (10,915) 6,328 14,970 (3,746) (27)
Balance, treasury, ending period (in shares) at Jun. 30, 2025       170,000,000        
Balance, beginning of period (in shares) at Mar. 31, 2025     683,000,000          
Balance, beginning of period (in usd) at Mar. 31, 2025 7,054 7,081 $ 683 $ (10,937) 6,309 14,968 (3,942) (27)
Balance, treasury, beginning period (in shares) at Mar. 31, 2025       170,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 91 91       91    
Other comprehensive income (loss) 196 196         196  
Stock issued under employee benefit plans and other 41 41   $ 22 19      
Dividends declared on common stock (89) (89)       (89)    
Balance, end of period (in shares) at Jun. 30, 2025     683,000,000          
Balance, end of period (in usd) at Jun. 30, 2025 7,293 7,320 $ 683 $ (10,915) 6,328 14,970 (3,746) (27)
Balance, treasury, ending period (in shares) at Jun. 30, 2025       170,000,000        
Balance, beginning of period (in shares) at Dec. 31, 2025     683,000,000          
Balance, beginning of period (in usd) at Dec. 31, 2025 $ 6,102 6,129 $ 683 $ (10,873) 6,368 13,705 (3,754) (27)
Balance, treasury, beginning period (in shares) at Dec. 31, 2025 169,213,617     169,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 111 111       111    
Other comprehensive income (loss) (65) (65)         (65)  
Stock issued under employee benefit plans and other (in shares)       (3,000,000)        
Stock issued under employee benefit plans and other 41 41   $ 168 (127)      
Dividends declared on common stock (10) (10)       (10)    
Balance, end of period (in shares) at Jun. 30, 2026     683,000,000          
Balance, end of period (in usd) at Jun. 30, 2026 $ 6,179 6,206 $ 683 $ (10,705) 6,241 13,806 (3,819) (27)
Balance, treasury, ending period (in shares) at Jun. 30, 2026 166,499,043     166,000,000        
Balance, beginning of period (in shares) at Mar. 31, 2026     683,000,000          
Balance, beginning of period (in usd) at Mar. 31, 2026 $ 6,016 6,043 $ 683 $ (10,737) 6,214 13,685 (3,802) (27)
Balance, treasury, beginning period (in shares) at Mar. 31, 2026       167,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 126 126       126    
Other comprehensive income (loss) (17) (17)         (17)  
Stock issued under employee benefit plans and other (in shares)       (1,000,000)        
Stock issued under employee benefit plans and other 59 59   $ 32 27      
Dividends declared on common stock (5) (5)       (5)    
Balance, end of period (in shares) at Jun. 30, 2026     683,000,000          
Balance, end of period (in usd) at Jun. 30, 2026 $ 6,179 $ 6,206 $ 683 $ (10,705) $ 6,241 $ 13,806 $ (3,819) $ (27)
Balance, treasury, ending period (in shares) at Jun. 30, 2026 166,499,043     166,000,000